GlassScriptPhysician profile
Jenna King
NPI 1588108187
$1,959.09
in general payments reported to CMS, 2019-2025
19 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $711 · 2022: $611 · 2023: $264 · 2024: $154 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Education: $14.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.28 |
| Education | $14.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.04 | 2021-2025 | |
| Janssen Biotech, INC. | $489.58 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $322.13 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $145.77 | 2021-2025 | |
| Pfizer INC. | $87.76 | 2021-2022 | |
| Amgen INC. | $57.53 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $42.17 | 2023-2024 | Odomzo, Blu-U |
| Genentech USA, INC. | $37.16 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.16 | 2022-2023 | Sotyktu |
| Allergan, INC. | $32.27 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $30.24 | 2021-2022 | |
| Dermavant Sciences, INC. | $30.11 | 2023 | Vtama |
| Almirall LLC | $22.39 | 2021 | |
| Ucb, INC. | $22.36 | 2025 | Bimzelx |
| Incyte Corporation | $21.59 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $20.20 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.39 | 2024 | Xifaxan |
| Galderma Laboratories, L.P. | $12.07 | 2022 | |
| Mayne Pharma Commercial LLC | $8.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.